ESMO关于癌症幸存者管理的专家共识声明:促进欧洲高质量幸存者护理与研究
ESMO发布专家共识,明确癌症幸存者护理的五大组成部分,包括身体、心理、社会及经济影响、复发与第二癌症监测、预防与健康促进;护理可通过整合初级保健与肿瘤服务的结构化模式提供,模式选择需适应当地实际;并提出研究议程应包含大数据平台与创新干预开发。
要点
- 幸存者护理包含五大组成部分:身体影响、心理影响、社会/工作/经济影响、复发与第二癌症监测、预防与健康促进。
- 护理可由结构化护理模式提供,包括整合初级保健与肿瘤服务的共享模式,模式选择需适应当地实际。
- 研究议程应由医疗提供者、研究者、政策制定者、患者及照护者共同参与定义,优先建立大数据平台与开发创新干预。
核心结论
- ESMO可积极推动肿瘤学界发展高质量幸存者护理项目、提供教育材料并支持开创性研究。
研究设计与样本
- ESMO专家共识声明,反思幸存者护理的不同组成部分、现有模式与优先事项。
主要发现
- 识别出幸存者护理的五个主要组成部分:癌症的身体影响与慢性医疗状况、心理影响、社会/工作/经济影响、复发与第二癌症监测、癌症预防与整体健康福祉促进。
- 幸存者护理可通过结构化护理模式提供,包括但不限于整合初级保健与肿瘤服务的共享模式。
- 护理模式的选择必须适应当地实际情况。
- 高质量护理应通过以下方式加速:制定聚焦且共享的欧洲推荐、创建促进协调护理实施的工具、为医疗团队和患者提供幸存者教育项目。
- 研究议程应包含:建立大数据平台收集幸存者与健康对照的长期真实世界数据,以理解患者资源/需求/偏好及幸存者问题的生物学决定因素;开发聚焦幸存者护理主要组成部分的创新有效干预。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship. DESIGN AND METHODS: Herein, we reflected on the different components of survivorship care, existing models and priorities, in order to facilitate the promotion of high-quality European survivorship care and research. RESULTS: We identified five main components of survivorship care: (i) physical effects of cancer and chronic medical conditions; (ii) psychological effects of cancer; (iii) social, work and financial effects of cancer; (iv) surveillance for recurrences and second cancers; and (v) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High-quality care should be expedited by the generation of: (i) focused and shared European recommendations, (ii) creation of tools to facilitate implementation of coordinated care and (iii) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers, patients and caregivers. The following patient-centered survivorship research areas were highlighted: (i) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to (a) understand the resources, needs and preferences of patients with cancer, and (b) understand biological determinants of survivorship issues, and (ii) develop innovative effective interventions focused on the main components of survivorship care. CONCLUSIONS: The European Society for Medical Oncology (ESMO) can actively contribute in the efforts of the oncology community toward (a) promoting the development of high-quality survivorship care programs, (b) providing educational material and (c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.
引用
- Vaz-Luis I, Masiero M, Cavaletti G, et al. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol. 2022. PMID: 35963481. doi:10.1016/j.annonc.2022.07.1941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。